William Scott

Cinven Ltd. operates as an investment firm. It focus on different sectors including business services, consumer, financial services, healthcare, industrials, and technology, media and telecommunications (TMT). The company was founded in 1977 and is headquartered in St Peter Port, Guernsey.

FRM Investment Management Ltd. is a fund distributor and part of the Financial Risk Management group, a hedge fund-of-funds. FRM was founded in 1991 and is located in St. Peter Port, UK. As part of the group, the firm has its operations in London, New York, Tokyo, Sydney and Guernsey. The company was founded in 1991 and is located in St. Peter Port, Guernsey.

Close Bank (Guernsey) Ltd. is a commercial bank based in Guernsey. The British company operates as a nationally chartered commercial bank.

SPL Parallel Private Equity (PE2) IC Ltd. is a closed-end investment company. Its investment objective is to realise its assets within the shortest period of time consistent with achieving a reasonable realisation price for such assets. The company was founded on December 21, 2006 and is headquartered in Saint Peter Port, the United Kingdom.

SPL Guernsey ICC Ltd. provides investment advisory services. The company is headquartered in St. Peter Port, the United Kingdom.

The Flight & Partners Recovery Fund Ltd. Is a closed end investment company. Its investment objective is to generate total returns over the long term with limited risk to shareholders subscriptions. The company was founded on January 31, 2008 and is headquartered in St. Peter Port, Guernsey.

The Chartered Institute For Securities & Investment operates as securities and investment educational institute. It is the professional body for those who work in the securities and investment industry in the UK and in a growing number of major financial centres round the world. The company was founded in 1992 and is headquartered in London, the United Kingdom.

Pershing Square Holdings Ltd. is a closed-end investment fund. Its investment objective is to preserve capital and to seek maximum, long-term capital appreciation commensurate with reasonable risk. The company seeks to achieve its investment objective through long and short positions in equity or debt securities of public U.S. and non-U.S. issuer?s derivative instruments and any other financial instruments. Pershing Square Holdings was founded on February 2, 2012 and is headquartered in St. Peter Port, the United Kingdom.

Cinven Partners LLP provides investment advisory and monitoring services. The company is headquartered in London, the United Kingdom.

Axiom European Financial Debt Fund Ltd. operates as a closed-ended investment company, which is managed by Axiom Alternative Investments SARL. The firm seeks to identify and invest in opportunities presented by the Basel III and Solvency II transitions in Europe. It also intends to invest in other financial institutional instruments, being financial instruments issued by European financial institutions, including without limitation senior debt, which do not constitute regulatory capital instruments. The company was founded on October 7, 2015 and is headquartered in St. Peter Port, the United Kingdom.

Cevine Capital Management VI (No.1) Feeder LP, Inc. operates as a private equity fund. The company was founded in 2015 and is headquartered in St. Peter Port, the United Kingdom.

SPL Private Finance (PF2) IC Ltd. is a closed-end investment fund and trust. Its objective is to manage the fund’s portfolio with a view to realizing its assets within the shortest period of time consistent with achieving a reasonable realization price for such assets and with the intention of disposing of all such assets. The company was founded on December 21, 2006 and is headquartered in St. Peter Port, the United Kingdom.

Cevine Capital Management VII (No. 1) Feeder LP, Inc. operates as a private equity fund. The company is headquartered in St. Peter Port, Guernsey.

RTW Biotech Opportunities Ltd. invests in companies located across the globe primarily in United States, Europe and China. The fund targets companies operating in the fields of biopharma and medtech. It provides financing for early and later stage capital requirements.